The FDA issued warning letters to 30 telehealth companies over misleading claims about compounded versions of popular ...

If you've taken a GLP-1 medication, tell us the good, the bad, the unexpected, or the confusing things you wish someone had ...

The blockbuster GLP-1 drugs that have reshaped the treatment of diabetes and obesity may help prevent multiple substance use ...

Glucagon-like peptide 1 (GLP-1) receptor agonists are a class of Type 2 diabetes drugs that improves blood sugar and may also lead to weight loss. These drugs — including ...

A November 2025 Kaiser Family Foundation poll found that 1 in 8 U.S. adults have tried a GLP-1 medication for weight loss, diabetes or another condition. And we expect that number to rise now that one ...

Drug executives say only their GLP-1 drugs are safe for treating obesity and diabetes as they wage a year-long campaign to ...

People struggling with many addictions, ranging from opioids to gambling, are reporting similar experiences in clinics, on social media and around dinner tables.

GLP-1s are changing the menu landscape for restaurants as diners fundamentally change how they eat. Here's what you'll start ...

Research is quickly catching up. In the last few years, studies have linked GLP-1 drugs like Ozempic and Wegovy with fewer ...

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

Doctors break it down.

GLP-1 drugs may help boost heart attack recovery by lowering the risk of major complications, an animal study suggests.